X0508 4 2026-02-20 0 0002022416 Silexion Therapeutics Corp SLXN 0002048879 Peled Amnon 55 NACHMANI ST TEL AVIV L3 6777634 ISRAEL 1 0 0 0 0 Ordinary Shares 2026-02-20 4 A 0 7576 0 A 8237 D Stock Option (right to buy Ordinary Shares) 1.65 2026-02-20 4 A 0 8904 0 A 2027-02-12 2036-02-12 Ordinary Shares 8904 8904 D Stock Option (right to buy Ordinary Shares) 18.90 2026-02-09 2035-02-09 Ordinary Shares 780 780 D The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of fully vested restricted share units (RSUs), which were immediately settled for underlying ordinary shares, par value $0.0135 per share, of the Issuer ("ordinary shares"), in respect of the Reporting Person's director services to the Issuer. The grant was approved by the Issuer's board of directors. The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of options to purchase ordinary shares, which grant was approved by the Issuer's board of directors. The options reported in this row vest in their entirety on the one-year anniversary of, and expire on the ten-year anniversary of, the date of approval of their grant by the Issuer's board of directors. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. /s/ Mirit Horenshtein Hadar, Attorney-in-fact 2026-02-23